Magazine

Use of Plerixafor in Predicted and ProvenPoorMobilizer( according to GITMO criteria). Experience of Tor Vergata University Polyclinic.

Authors: Massimiliano Postorino, Alessandro Lanti, Eleonora Florelli, Angelo Salvatore Ferraro, Oana Marilena Chiuru,Raffaella Massarelli, Luca Franceschini, Giorgia Guiducci,Provenzano I., Livio Pupo, Anna Giulia Zizzari, GaspareAdorno, Maria Cantonetti, Giancarlo Isacchi and Sergio Amadori. (2012).

Date: 2012

Scope of interest: Hematology/Transfusion Medicine

You may also be interested in:

Magazine 5.09

Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy.

Authors: Pontali et al

Date: sep 2018

Scope of interest: infectious diseases/pen health

Read details

Magazine 4.9

High HIV-1 diversity in immigrants residing in Italy (2008-2017).

Authors: Maggiorella MT et al

Date: 20 Feb 2023

Scope of interest: infectious disease

Read details

Report/Poster of Convention/Congress Act

– Outpatient management of anaemia secondary to epistaxis in patients with Rendu-Osler disease: the role of intravenous martial therapy

Authors: Maria Trimboli(1) - Federico De Angelis (1) - Francesca Docimo (1) - Elena Gigliotti(1) - Giorgia Guiducci(1) - Paolo Paesano (1) - Ida Provenzano (1) - Cristina D'Amico (1) - Simona Fornella (1) - Sonia Romoli(1) - Augusto Di Folco (1) - Carla Gargiulo (

Date: 2022

Scope of interest: Clinical pathology

Read details